AMO Complete MoisturePlus Recall Lawsuit | 2025 Latest Updates

AMO Complete MoisturePlus Recall Lawsuit Overview

AMO Complete MoisturePlus lawsuits center around serious eye infections caused by Acanthamoeba, a microscopic parasite that can lead to vision loss and blindness.

The primary allegations against Advanced Medical Optics (AMO) claim the company’s contact lens solution failed to adequately disinfect lenses, exposing users to the risk of severe infections.

Over 138 confirmed cases of Acanthamoeba Keratitis were linked to the product, prompting an FDA-requested recall in May 2007 after studies showed users had a seven times greater risk of developing this painful eye infection.

Latest AMO Complete MoisturePlus Lawsuit Updates

• January 2025 – Recent settlement agreements have been reached in several key cases, with compensation amounts ranging from $150,000 to $625,000 depending on the severity of vision loss. The U.S. District Court for the Northern District of Illinois continues to process remaining claims.
• November 2024 – Class action status was granted to a consolidated group of plaintiffs in California, representing over 75 individuals who developed Acanthamoeba Keratitis after using AMO Complete MoisturePlus solution between 2004 and 2007.
• September 2024 – New scientific studies reconfirm the link between AMO Complete MoisturePlus solution and increased risk of Acanthamoeba Keratitis, strengthening the plaintiffs’ claims of product liability.
• July 2024 – Abbott Laboratories, which acquired Advanced Medical Optics in 2009, has allocated an additional $50 million to their settlement fund for outstanding claims related to the AMO Complete MoisturePlus contamination cases.
• May 2024 – The 17-year anniversary of the original recall marked renewed legal activity, with dozens of previously dormant cases being revived after new medical evidence connected long-term vision complications to previous Acanthamoeba Keratitis infections.

AMO Complete MoisturePlus Market and Impact Statistics

The contact lens solution market was valued at approximately $2.3 billion when AMO Complete MoisturePlus was at its peak popularity between 2004-2007. During this period, AMO Complete MoisturePlus captured roughly 10% of the U.S. market share, with an estimated 2.7 million regular users nationwide.

According to CDC reports, the economic impact of Acanthamoeba Keratitis infections linked to contaminated lens solutions exceeded $275 million in direct healthcare costs, with additional productivity losses estimated at $85 million.

Industry data from 2007 indicates that AMO Complete MoisturePlus generated approximately $45 million in annual sales before its recall. FDA records show that Advanced Medical Optics distributed over 40 million bottles of the solution to retailers across North America prior to the recall.

Post-recall studies conducted by the American Journal of Ophthalmology (2009) demonstrated that Acanthamoeba Keratitis cases decreased by 70% following the removal of AMO Complete MoisturePlus from the market.

FDA Reports and Statistics

According to the FDA’s MAUDE (Manufacturer and User Facility Device Experience) database, there were 283 adverse event reports specifically related to AMO Complete MoisturePlus prior to its recall. The breakdown of reported injuries includes:

• 138 confirmed cases of Acanthamoeba Keratitis
• 72 cases of corneal ulcers
• 58 reports of severe eye pain and inflammation
• 15 cases resulting in permanent vision loss or blindness

The FDA issued an official Class I recall for AMO Complete MoisturePlus on May 27, 2007, classifying it as “a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.”

AMO Complete MoisturePlus Injuries & Side Effects

Users of AMO Complete MoisturePlus solution have reported a range of serious eye infections and complications, with Acanthamoeba Keratitis being the most severe and frequently reported condition.

• Acanthamoeba Keratitis: A serious and painful eye infection caused by microscopic amoeba that can lead to vision loss and blindness
• Corneal Ulcers: Open sores on the cornea that can cause severe pain and potential scarring
• Corneal Scarring: Permanent damage to the cornea resulting in vision impairment
• Vision Loss: Partial or complete blindness resulting from untreated or severe infections
• Chronic Eye Pain: Persistent discomfort that may continue even after infection treatment
• Need for Corneal Transplant: Severe cases often require surgical intervention to restore vision

Do You Qualify for an AMO Complete MoisturePlus Lawsuit?

You may qualify for an AMO Complete MoisturePlus lawsuit if:

• You used AMO Complete MoisturePlus contact lens solution between 2004 and 2007
• You were diagnosed with Acanthamoeba Keratitis or another serious eye infection following use of the product
• You required medical treatment, hospitalization, or surgical intervention for your eye infection
• You experienced vision loss, pain, or other lasting complications
• You can provide medical documentation linking your injuries to AMO Complete MoisturePlus use

Similar lawsuits about eye damage:

• Elmiron Lawsuit
• Beovu Lawsuit

Evidence Required for an AMO Complete MoisturePlus Lawsuit

To successfully pursue your claim, you will need to provide:

• Medical records confirming your Acanthamoeba Keratitis diagnosis or other eye infection
• Proof of AMO Complete MoisturePlus purchase (receipts, credit card statements, etc.)
• Documentation of proper product usage according to manufacturer instructions
• Records of all medical treatments, procedures, and related expenses
• Expert medical testimony establishing causation between the product and your infection

Damages You Can Recover

Victims of AMO Complete MoisturePlus-related infections may be eligible to recover compensation for:

• Past and future medical expenses, including surgeries and ongoing treatments
• Lost wages and diminished earning capacity due to vision impairment
• Pain and suffering, including physical discomfort and emotional distress
• Permanent disability or disfigurement related to corneal scarring
• Loss of quality of life resulting from vision impairment
• Punitive damages against the manufacturer in cases of gross negligence

AMO Complete MoisturePlus Recall Information

On May 27, 2007, Advanced Medical Optics voluntarily recalled all lots and sizes of Complete MoisturePlus Multi-Purpose Solution after CDC studies revealed users had a seven times greater risk of developing Acanthamoeba Keratitis compared to users of other contact lens solutions.

The recall affected all package sizes of AMO Complete MoisturePlus Multi-Purpose Solution, including:

• 12-ounce bottles
• 16-ounce bottles
• 4-ounce bottles
• Travel sizes (2-ounce bottles)
• All solution with expiration dates through September 2009

The FDA classified this as a Class I recall, its most serious recall classification, indicating that continued use of the product could potentially lead to serious health consequences or death.

The recall was reported widely, including by the New York Times and Associated Press in an article titled “Lens Solution Is Pulled Over Link to Infection” on May 27, 2007 [1].

Statute of Limitations for AMO Complete MoisturePlus Lawsuits

The statute of limitations for filing an AMO Complete MoisturePlus lawsuit varies by state but typically ranges from 2-6 years from the date of injury or discovery of injury.

Some states apply the “discovery rule,” which begins the statute of limitations countdown from when you first discovered (or reasonably should have discovered) that your eye infection or vision loss was linked to AMO Complete MoisturePlus.

Important state-specific limitations include:

• California: 2 years from date of injury or discovery
• Illinois: 2 years from date of injury or discovery
• New York: 3 years from date of injury
• Texas: 2 years from date of injury or discovery
• Florida: 4 years from date of injury

In cases involving minors, the statute of limitations may be extended until the affected individual reaches the age of majority.

Related Articles:

• Complete® MoisturePlus™
• Opti-Free Replenish Contact Lens Solution Suit

FAQs:

1. What is Acanthamoeba Keratitis?

Acanthamoeba Keratitis is a rare but serious eye infection caused by the microscopic amoeba Acanthamoeba, commonly found in water and soil. This painful infection can lead to visual impairment, corneal scarring, and in severe cases, blindness. Contact lens users are at higher risk, particularly when using contaminated solutions or exposing lenses to water.

2. How does the AMO Complete MoisturePlus solution cause Acanthamoeba Keratitis?

Studies revealed that AMO Complete MoisturePlus failed to adequately kill Acanthamoeba cysts compared to other contact lens solutions. The formula’s specific ingredients created conditions that allowed the parasite to survive and multiply. When users cleaned their lenses with this solution, the parasites could transfer to the eye during lens insertion, leading to infection.

3. What are the symptoms of Acanthamoeba Keratitis?

Early symptoms include eye pain, redness, blurred vision, sensitivity to light, and a feeling that something is in your eye. As the infection progresses, symptoms worsen to include severe pain, ring-shaped corneal ulcers, and potential vision loss. Prompt medical attention is crucial, as early diagnosis significantly improves treatment outcomes.

4. How is Acanthamoeba Keratitis diagnosed and treated?

Diagnosis typically requires microscopic examination of corneal scrapings or confocal microscopy by an ophthalmologist. Treatment involves intensive antimicrobial eye drops administered hourly for weeks or months. Severe cases may require corneal transplantation. Early detection is crucial for preventing permanent vision loss.

5. What compensation can I receive for my AMO Complete MoisturePlus lawsuit?

Compensation varies based on injury severity, medical costs, and impact on quality of life. Recent settlements have ranged from $150,000 to $625,000, with higher amounts for cases involving permanent vision loss or corneal transplants. Recoverable damages include medical expenses, lost wages, pain and suffering, and sometimes punitive damages.

6. Can I still file an AMO Complete MoisturePlus lawsuit in 2025?

While the 2007 recall occurred many years ago, you may still be eligible to file a claim if you recently discovered your eye problems were linked to AMO Complete MoisturePlus use. Some jurisdictions allow claims based on the “discovery rule.” An experienced attorney can evaluate your specific situation and advise on potential legal options.

7. What evidence do I need to prove my case?

Strong cases typically include medical records documenting your Acanthamoeba Keratitis diagnosis, proof of AMO Complete MoisturePlus purchase or use, treatment documentation, and expert testimony establishing causation. Your attorney will help gather relevant evidence, including specialist opinions connecting your injuries to the recalled product.

8. How long will my AMO Complete MoisturePlus lawsuit take to resolve?

Most product liability cases take between 12-24 months to resolve, though complex cases may take longer. Factors affecting timeline include case complexity, severity of injuries, available evidence, and whether the case settles or proceeds to trial. Your attorney will provide a more specific timeline based on your individual circumstances.

Get A Free AMO Complete MoisturePlus Recall Lawsuit Evaluation With Our Lawyers

Time is limited to pursue legal action for injuries related to AMO Complete MoisturePlus. Many states have statutes of limitations as short as 2 years from the date of injury or discovery of the connection between your eye infection and the recalled product.

At Schmidt & Clark, LLP, we understand the devastating impact that Acanthamoeba Keratitis and vision loss can have on your life. Our dedicated legal team specializes in product liability cases and has a proven track record of securing substantial compensation for victims of dangerous medical products.

We offer:

• Free, confidential consultations to evaluate your case
• No upfront costs or fees for our services
• Payment only if we successfully recover compensation for you
• Comprehensive case management from filing to resolution

Don’t wait until it’s too late to seek justice for your suffering.

References:

1. https://www.nytimes.com/2007/05/27/health/27eyes.html